Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations | Patent Publication Number 20230085549
US 20230085549 A1Publication DateMar 16, 2023
Original Assignee
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsSrihari Gopal
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.